In conclusion, drug-resistant BC cells-derived exosomal miR-221-3p could promote drug resistance of BC cells to ADR by targeting PIK3R1 via PI3K/AKT signaling pathway in vitro and in vivo (Figure 8). Here, AKT1 is linked to breast cancer.